The binding of cyclin D1 to CDKs (CDK4 and CDK6) drives G1 to S phase transition and disease progression in tumors.41 CDK4/6 inhibitors prevent RB1 phosphorylation and E2F transcription and thereby induce G1 cell cycle arrest and block cancer progression. The gene discussed is CDK4; the disease is cancer.